FDA GCP Inspection Trends Identified Using AI

FDA GCP Inspection Trends Identified Using AI Presented Tuesday, June 14, 2022 Watch this informative 1-hour presentation with insights into FDA GCP inspection trends, including intelligence on data integrity and clinical investigator enforcement activity. Speakers: Jerry Chapman, Redica Systems Fran Lambetecchio, Regulatory Associates What is covered: Importance and challenges of human clinical studies Data sources and evaluation using AI Tools What we can learn from US FDA Inspections of Clinical Investigators A deeper dive into FDA Warning Letters and 483 data with some surprises